Carboxypeptidase [EPC]

239 reported adverse events

Drugs of this class: GLUCARPIDASE

These side effects are most commonly reported by patients taking drugs of the Carboxypeptidase [EPC] class:

# Side effect Count
0 OFF LABEL USE 39
1 UNDERDOSE 38
2 LABORATORY TEST INTERFERENCE 34
3 DRUG EFFECT INCOMPLETE 33
4 TOXICITY TO VARIOUS AGENTS 28
5 ACUTE KIDNEY INJURY 27
6 BLOOD CREATININE INCREASED 26
7 REBOUND EFFECT 24
8 RENAL FAILURE 21
9 DRUG INEFFECTIVE 20
See all common reactions for Carboxypeptidase [EPC]

Drugs of the Carboxypeptidase [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LABORATORY TEST INTERFERENCE 34 0.0521
1 LEUKAEMIC LYMPHOMA 1 0.0370
2 OSTEOSARCOMA RECURRENT 1 0.0278
3 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 2 0.0189
4 FALSE POSITIVE INVESTIGATION RESULT 10 0.0133
5 OSTEOSARCOMA METASTATIC 1 0.0119
6 CRYSTAL NEPHROPATHY 3 0.0085
7 DRUG CLEARANCE DECREASED 7 0.0085
8 CRYSTALLURIA 2 0.0056
9 REBOUND EFFECT 24 0.0042
See all enriched reactions for Carboxypeptidase [EPC]